Sinclair Pharma (SPH)
SPH Share PerformanceMore
|52 week high||36.750 26/05/16|
|52 week low||26.000 28/09/16|
|52 week change||-1.125 (-3.19%)|
|4 week volume||17,494,333 27/04/17|
Latest News« previous» nextMore
26/04/2017 - 13:50 StockMarketWire
Sinclair Pharma has announced that all resolutions put to its Annual General Meeting held earlier today were duly passed. ...
26/04/2017 - 10:50 RNS
Notification of the result of any voting at an AGM
19/04/2017 - 16:30 StockMarketWire
N+1 Singer today reaffirms its buy investment rating on Sinclair IS Pharma PLC (LON:SPH) and cut its price target to 37p...
30/03/2017 - 16:55 RNS
Publication of a company's annual financial report
30/03/2017 - 07:00 RNS
28/03/2017 - 07:15 RNS
27/03/2017 - 13:03 StockMarketWire
Sinclair Pharma has confirmed the appointment of RBC Capital Markets to act as its joint broker alongside Peel Hunt, wit...
27/03/2017 - 10:30 RNS
|Dividend yield||0 %|
Equity Research (SPH)
Sinclair Pharma plc
During 2016, Sinclair has been transformed into a streamlined pure-play aesthetics company with a concentrated, highly competitive, portfolio of differentiated injectable products. Effective, longer-...
Sinclair Pharma plc
Sinclair has evolved into a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics products. These products target unmet clinical...
Latest discussion posts More
“Very good comprehensive research note posted under today's RNS. Worth a read for anyone with an interest in SPH, of which there appears to be very few. Chozza”▼
“Huge volume (over 9M) traded so far this morning, and price still rising. Lokks like others are anticipating good results tomorrow. GLA”▼
“Cut and paste from official results?. Barcelona, 27th February, 2017.- Almirall, the global pharmaceutical company based in Barcelona, has posted its full-year 2016 results ...”▼
Codes & Symbols
|Symbols||SPH, LSE:SPH, SPH.L, SPH:LN, LON:SPH, XLON:SPH|